Vishal is an EIR and CEO of Triveni Bio. He was previously Head of Portfolio Strategy and Alliances at Flagship Pioneering, where he led scientific and business strategy across multiple portfolio companies. Prior to Flagship, Vishal was VP of Strategy and Scientific Engagement at the Novartis, where he led R&D strategy, competitive intelligence, portfolio management, and other functions. He held roles of increasing responsibility at Merck KGaA as well as the U.S. Department of State and U.S. Senate – where he helped draft the Affordable Care Act. Vishal continues to serve as a reservist in the U.S. Navy. He received a PhD in biochemistry from Harvard, MBA from MIT, and BS in bioengineering from U. Illinois.